These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6429856)

  • 21. Gallbladder dysfunction enhances physical density but not biochemical metastability of biliary vesicles.
    Sunami Y; Tazuma S; Kajiyama G
    Dig Dis Sci; 2000 Dec; 45(12):2382-91. PubMed ID: 11258563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total biliary protein, mucus glycoproteins, cyclic-AMP, and apolipoproteins in the gallbladder bile of patients with cholesterol stones and stone-free controls.
    Swobodnik W; Wenk H; Janowitz P; Hagert N; Kratzer W; Berghold J; Zhang Y; Bittner R; Schusdziarra V; Ott R
    Scand J Gastroenterol; 1991 Jul; 26(7):771-8. PubMed ID: 1654593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative potency of cholesterol crystallization-effector proteins in supersaturated model bile systems: association with vesicle transformation.
    Hattori Y; Tazuma S; Yamashita G; Kajiyama G
    J Gastroenterol Hepatol; 1998 Nov; 13(11):1161-70. PubMed ID: 9870806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a concanavalin A-binding biliary glycoprotein on nucleation time of gallbladder bile.
    Nakano A; Masuzawa S; Ogura K; Fukazawa S; Nakamoto K; Sekido H; Fukushima T; Tsuchiya S
    Gastroenterol Jpn; 1990 Feb; 25(1):88-92. PubMed ID: 2307338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein A-I stabilizes phospholipid lamellae and thus prolongs nucleation time in model bile systems: an ultrastructural study.
    Tao S; Tazuma S; Kajiyama G
    Biochim Biophys Acta; 1993 Feb; 1166(1):25-30. PubMed ID: 8431489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quantitative determination of apolipoprotein A in human serum by laser nephelometry].
    Girault A; Loiseau D; Girault M
    Ric Clin Lab; 1981; 11 Suppl 2():19-29. PubMed ID: 6798675
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones.
    Lee SP; LaMont JT; Carey MC
    J Clin Invest; 1981 Jun; 67(6):1712-23. PubMed ID: 7240416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of cholesterol gallstone disease.
    Méndez-Sánchez N; Cárdenas-Vázquez R; Ponciano-Rodríguez G; Uribe M
    Arch Med Res; 1996; 27(4):433-41. PubMed ID: 8987174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in plasma apolipoproteins A-I, A-II, and B, and lipoprotein cholesterol after jejunoileal bypass.
    Goldberg RB; Weinberg RB; Landau RL
    Gastroenterology; 1983 Apr; 84(4):732-6. PubMed ID: 6402411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
    van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
    Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a quantitative assay for cholesterol crystal growth in human gallbladder bile.
    Ginanni Corradini S; Cantafora A; Capocaccia L; Della Guardia P; Giacomelli L; Angelico M
    Biochim Biophys Acta; 1994 Aug; 1214(1):63-72. PubMed ID: 8068730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium and the anionic polypeptide fraction (APF) have opposing effects on cholesterol crystallization in model bile.
    Konikoff FM; Lechene de la Porte P; Laufer H; Domingo N; Lafont H; Gilat T
    J Hepatol; 1997 Oct; 27(4):707-15. PubMed ID: 9365047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of a novel human 15 kd cholesterol crystallization inhibitor protein in bile.
    Secknus R; Yamashita G; Ginanni Corradini S; Chernosky A; Williams C; Hays L; Secknus MA; Holzbach RT
    J Lab Clin Med; 1996 Feb; 127(2):169-78. PubMed ID: 8636645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of biliary diversion on rat mesenteric lymph apolipoprotein-I and high density lipoprotein.
    Bearnot HR; Glickman RM; Weinberg L; Green PH; Tall AR
    J Clin Invest; 1982 Jan; 69(1):210-7. PubMed ID: 6798073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
    Angquist KA; Johnson O; Ericsson M; Tollin C
    Acta Chir Scand; 1982; 148(8):675-8. PubMed ID: 6820598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concanavalin-A-extractable non-mucous glycoprotein concentrations in gallbladder bile of cholesterol gallstone patients.
    Berghold J; Swobodnik W; Wenk H; Classen M
    Scand J Gastroenterol; 1994 Dec; 29(12):1135-9. PubMed ID: 7886403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Concentration of lipids and apolipoproteins A-I, A-II and E in blood plasma of men with chronic alcoholism].
    Triufanov VF; Usatenko MS; Bokiĭ IV
    Vopr Med Khim; 1981; 27(3):397-402. PubMed ID: 6792781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of cholesterol crystallization effector proteins on vesicle fusion in supersaturated model bile.
    Hattori Y; Tazuma S; Yamashita G; Kajiyama G
    J Gastroenterol Hepatol; 1999 Jul; 14(7):669-74. PubMed ID: 10440211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The validity of the cholesterol nucleation assay.
    de Bruijn MA; Noordam C; Goldhoorn BG; Tytgat GN; Groen AK
    Biochim Biophys Acta; 1992 Jan; 1138(1):41-5. PubMed ID: 1737069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The physical presence of gallstone modulates
    Portincasa P; van Erpecum KJ; Di Ciaula A; Wang DQ
    Gastroenterol Rep (Oxf); 2019 Feb; 7(1):32-41. PubMed ID: 30792864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.